NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
14 hedge funds and large institutions have $2.27M invested in NeuBase Therapeutics, Inc. Common Stock in 2013 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
1 | +$435K | |
2 | +$140K | |
3 | +$88K | |
4 |
Geode Capital Management
Boston,
Massachusetts
|
+$66.1K |
5 |
Morgan Stanley
New York
|
+$21K |
Top Sellers
1 | -$97.6K | |
2 | -$87K | |
3 | -$47K | |
4 |
First Manhattan
New York
|
-$13K |
5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$11K |